Not a Member? Register Now
Email this page
Send the page "" to a friend, relative, colleague or yourself.
Separate multiple email address with a comma
We do not record any personal information entered above.
Thank you. Your email has been sent.
FDA Date: 10/23/2017
Vigabatrin REMS
Goal of the Vigabatrin REMS Program
The goal of the Vigabatrin REMS Program is to mitigate the risk of vision loss associated with vigabatrin by:• Ensuring that healthcare providers are educated about the risk of vision loss, the need to counsel patients about the risk, and the need for periodic visual monitoring.• Ensuring that vigabatrin is only dispensed to patients with documentation that patients are informed about the risk of vision loss associated with vigabatrin and the need for periodic visual monitoring.
• Elements to Assure Safe Use• Implementation System